OM — Outset Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $65.19m
- -$7.52m
- $119.48m
Annual cashflow statement for Outset Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -132 | -163 | -173 | -128 | -81.7 |
| Depreciation | |||||
| Non-Cash Items | 22.1 | 33.2 | 36.4 | 31.6 | 28.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -25.6 | -21.1 | -0.773 | -25.7 | 2.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -130 | -146 | -131 | -116 | -46.3 |
| Capital Expenditures | -3.11 | -8.32 | -3.44 | -0.912 | -0.798 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -139 | -58 | 86.5 | 105 | -96.9 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -143 | -66.3 | 83 | 104 | -97.7 |
| Financing Cash Flow Items | — | — | — | -0.938 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 160 | 72.9 | 43.7 | 67.9 | 55.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -113 | -139 | -4.7 | 55.5 | -88.5 |